Search research articles
Contact Us
Filters
Showing results (411-420 of 435) with videos related to
Page
of 44
Sort By:
New Biotechnology
|
September 23, 2022
A COST Action on microbial responses to low pH: Developing links and sharing resources across the academic-industrial divide
Tamir Azizi, Laurine Carvalho De Araujo, Zeynep Cetecioglu, et al.
Molecular Biology of the Cell
|
August 10, 2012
Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicity
Aster Legesse-Miller, Irene Raitman, Erin M Haley, et al.
Diabetes Care
|
February 24, 2019
Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY)
Nicolai A Lund-Blix, Fran Dong, Karl Mårild, et al.
The American Journal of Gastroenterology
|
May 15, 2019
Gluten Intake and Risk of Celiac Disease: Long-Term Follow-up of an At-Risk Birth Cohort
Karl Mårild, Fran Dong, Nicolai A Lund-Blix, et al.
Diabetologia
|
March 19, 2024
No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts
Nicolai A Lund-Blix, Anne A Bjerregaard, German Tapia, et al.
Elife
|
February 22, 2018
Molecular coordination of <i>Staphylococcus aureus</i> cell division
Victoria A Lund, Katarzyna Wacnik, Robert D Turner, et al.
Pediatric Research
|
April 25, 2009
Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates
Katheryn E Nathe, Richard Parad, Linda J Van Marter, et al.
European Journal of Human Genetics : EJHG
|
July 4, 2001
Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world
A Lund, B Udd, V Juvonen, et al.
Bioorganic & Medicinal Chemistry
|
February 9, 2005
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor
Jin Li, Michael P Lynch, Kristin Lundy Demello, et al.
Molecular Microbiology
|
January 29, 2013
Laboratory adapted Escherichia coli K-12 becomes a pathogen of Caenorhabditis elegans upon restoration of O antigen biosynthesis
Douglas F Browning, Timothy J Wells, Fernanda L S França, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 435) with videos related to
Sort By:
Page
of 44
New Biotechnology
|
September 23, 2022
A COST Action on microbial responses to low pH: Developing links and sharing resources across the academic-industrial divide
Tamir Azizi, Laurine Carvalho De Araujo, Zeynep Cetecioglu, et al.
Molecular Biology of the Cell
|
August 10, 2012
Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicity
Aster Legesse-Miller, Irene Raitman, Erin M Haley, et al.
Diabetes Care
|
February 24, 2019
Gluten Intake and Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in Children at Increased Risk of the Disease: The Diabetes Autoimmunity Study in the Young (DAISY)
Nicolai A Lund-Blix, Fran Dong, Karl Mårild, et al.
The American Journal of Gastroenterology
|
May 15, 2019
Gluten Intake and Risk of Celiac Disease: Long-Term Follow-up of an At-Risk Birth Cohort
Karl Mårild, Fran Dong, Nicolai A Lund-Blix, et al.
Diabetologia
|
March 19, 2024
No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts
Nicolai A Lund-Blix, Anne A Bjerregaard, German Tapia, et al.
Elife
|
February 22, 2018
Molecular coordination of <i>Staphylococcus aureus</i> cell division
Victoria A Lund, Katarzyna Wacnik, Robert D Turner, et al.
Pediatric Research
|
April 25, 2009
Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates
Katheryn E Nathe, Richard Parad, Linda J Van Marter, et al.
European Journal of Human Genetics : EJHG
|
July 4, 2001
Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world
A Lund, B Udd, V Juvonen, et al.
Bioorganic & Medicinal Chemistry
|
February 9, 2005
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor
Jin Li, Michael P Lynch, Kristin Lundy Demello, et al.
Molecular Microbiology
|
January 29, 2013
Laboratory adapted Escherichia coli K-12 becomes a pathogen of Caenorhabditis elegans upon restoration of O antigen biosynthesis
Douglas F Browning, Timothy J Wells, Fernanda L S França, et al.
Page
of 44